208 related articles for article (PubMed ID: 1363339)
1. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
4. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine.
Connolly KM; Bogdanffy MS
J Histochem Cytochem; 1993 Jan; 41(1):1-6. PubMed ID: 7678022
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of PCNA labeling index in astrocytic tumors].
Beppu T; Arai H; Kanaya H; Sasaki K
No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
[TBL] [Abstract][Full Text] [Related]
12. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen expression in central nervous system neoplasms.
Allegranza A; Girlando S; Arrigoni GL; Veronese S; Mauri FA; Gambacorta M; Pollo B; Dalla Palma P; Barbareschi M
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):417-23. PubMed ID: 1721471
[TBL] [Abstract][Full Text] [Related]
14. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
[TBL] [Abstract][Full Text] [Related]
15. [A study on tongue cancer cell labeling using bromodeoxyuridine (BrdU) incorporation in vitro].
Li X; Zhao Q; He R; Zhou X; Chen W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):278-80. PubMed ID: 12539478
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer].
Ota T; Akaza H; Hattori K; Uchida K
Nihon Hinyokika Gakkai Zasshi; 1997 Oct; 88(10):868-73. PubMed ID: 9388366
[TBL] [Abstract][Full Text] [Related]
18. Quantification of hepatocytic proliferation in the laboratory mouse. A comparative study using immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression.
Lardelli P; Perentes E; Meier G; Navarro N; Ettlin RA
Exp Toxicol Pathol; 1994 Jul; 46(2):95-100. PubMed ID: 7987078
[TBL] [Abstract][Full Text] [Related]
19. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
20. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
